Cargando…
Anti-EGFR mAb cetuximab therapy increases T cell receptor (TCR) diversity in the peripheral blood and focuses TCR richness in the tumor microenvironment
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4646103/ http://dx.doi.org/10.1186/2051-1426-3-S2-P73 |
_version_ | 1782400915077070848 |
---|---|
author | Kansy, Benjamin A Lin, Yan Ding, Fei Gibson, Sandra Poveda Jie, Hyun-Bae Ferris, Robert L |
author_facet | Kansy, Benjamin A Lin, Yan Ding, Fei Gibson, Sandra Poveda Jie, Hyun-Bae Ferris, Robert L |
author_sort | Kansy, Benjamin A |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-4646103 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-46461032015-11-20 Anti-EGFR mAb cetuximab therapy increases T cell receptor (TCR) diversity in the peripheral blood and focuses TCR richness in the tumor microenvironment Kansy, Benjamin A Lin, Yan Ding, Fei Gibson, Sandra Poveda Jie, Hyun-Bae Ferris, Robert L J Immunother Cancer Poster Presentation BioMed Central 2015-11-04 /pmc/articles/PMC4646103/ http://dx.doi.org/10.1186/2051-1426-3-S2-P73 Text en Copyright © 2015 Kansy et al. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Poster Presentation Kansy, Benjamin A Lin, Yan Ding, Fei Gibson, Sandra Poveda Jie, Hyun-Bae Ferris, Robert L Anti-EGFR mAb cetuximab therapy increases T cell receptor (TCR) diversity in the peripheral blood and focuses TCR richness in the tumor microenvironment |
title | Anti-EGFR mAb cetuximab therapy increases T cell receptor (TCR) diversity in the peripheral blood and focuses TCR richness in the tumor microenvironment |
title_full | Anti-EGFR mAb cetuximab therapy increases T cell receptor (TCR) diversity in the peripheral blood and focuses TCR richness in the tumor microenvironment |
title_fullStr | Anti-EGFR mAb cetuximab therapy increases T cell receptor (TCR) diversity in the peripheral blood and focuses TCR richness in the tumor microenvironment |
title_full_unstemmed | Anti-EGFR mAb cetuximab therapy increases T cell receptor (TCR) diversity in the peripheral blood and focuses TCR richness in the tumor microenvironment |
title_short | Anti-EGFR mAb cetuximab therapy increases T cell receptor (TCR) diversity in the peripheral blood and focuses TCR richness in the tumor microenvironment |
title_sort | anti-egfr mab cetuximab therapy increases t cell receptor (tcr) diversity in the peripheral blood and focuses tcr richness in the tumor microenvironment |
topic | Poster Presentation |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4646103/ http://dx.doi.org/10.1186/2051-1426-3-S2-P73 |
work_keys_str_mv | AT kansybenjamina antiegfrmabcetuximabtherapyincreasestcellreceptortcrdiversityintheperipheralbloodandfocusestcrrichnessinthetumormicroenvironment AT linyan antiegfrmabcetuximabtherapyincreasestcellreceptortcrdiversityintheperipheralbloodandfocusestcrrichnessinthetumormicroenvironment AT dingfei antiegfrmabcetuximabtherapyincreasestcellreceptortcrdiversityintheperipheralbloodandfocusestcrrichnessinthetumormicroenvironment AT gibsonsandrapoveda antiegfrmabcetuximabtherapyincreasestcellreceptortcrdiversityintheperipheralbloodandfocusestcrrichnessinthetumormicroenvironment AT jiehyunbae antiegfrmabcetuximabtherapyincreasestcellreceptortcrdiversityintheperipheralbloodandfocusestcrrichnessinthetumormicroenvironment AT ferrisrobertl antiegfrmabcetuximabtherapyincreasestcellreceptortcrdiversityintheperipheralbloodandfocusestcrrichnessinthetumormicroenvironment |